2019
DOI: 10.1214/18-aoas1229
|View full text |Cite
|
Sign up to set email alerts
|

Modeling association in microbial communities with clique loglinear models

Abstract: There is a growing awareness of the important roles that microbial communities play in complex biological processes. Modern investigation of these often uses next generation sequencing of metagenomic samples to determine community composition. We propose a statistical technique based on clique loglinear models and Bayes model averaging to identify microbial components in a metagenomic sample at various taxonomic levels that have significant associations. We describe the model class, a stochastic search techniq… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
2
1
1

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 64 publications
(70 reference statements)
0
3
0
Order By: Relevance
“…Tools such as FLINT ( Valdes et al, 2019 ) and Kraken 2 ( Wood et al, 2019 ) facilitate the creation of microbial abundance profiles either from metagenomic whole-genome DNA sequencing (mWGS) or 16S-amplicon sequencing (16S) data. These abundance profiles are the stepping stones for downstream analyses such as differential abundance studies ( White et al, 2009 ), co-occurrence pattern discovery ( Dutilh et al, 2014 ; Fernandez et al, 2015 ; Fernandez et al, 2016 ; Weiss et al, 2016 ), Bayesian analyses ( Rahman Sazal et al, 2018 ; Adrian et al, 2019 ), biomarker identification ( Segata et al, 2011 ), multi-omics analyses ( IHMP Consortium, 2014 ; Aguiar-Pulido et al, 2016 ), and analyses of profiles from longitudinal studies ( Jose et al, 2019 ; Ruiz-Perez et al, 2019 ). Lower sequencing costs have resulted in an increasing number of larger deep sequencing metagenomic data sets ( Muir et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…Tools such as FLINT ( Valdes et al, 2019 ) and Kraken 2 ( Wood et al, 2019 ) facilitate the creation of microbial abundance profiles either from metagenomic whole-genome DNA sequencing (mWGS) or 16S-amplicon sequencing (16S) data. These abundance profiles are the stepping stones for downstream analyses such as differential abundance studies ( White et al, 2009 ), co-occurrence pattern discovery ( Dutilh et al, 2014 ; Fernandez et al, 2015 ; Fernandez et al, 2016 ; Weiss et al, 2016 ), Bayesian analyses ( Rahman Sazal et al, 2018 ; Adrian et al, 2019 ), biomarker identification ( Segata et al, 2011 ), multi-omics analyses ( IHMP Consortium, 2014 ; Aguiar-Pulido et al, 2016 ), and analyses of profiles from longitudinal studies ( Jose et al, 2019 ; Ruiz-Perez et al, 2019 ). Lower sequencing costs have resulted in an increasing number of larger deep sequencing metagenomic data sets ( Muir et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…Tools such as Flint [36] and Kraken 2 [40] facilitate the process to create detailed microbial abundance profiles for tens of thousands of genomes for both metagenomic whole-genome DNA sequencing (mWGS) as well as 16S-amplicon sequencing (16S). The abundance profiles are the stepping stones for downstream analyses such as differential abundance studies [38], co-occurrence pattern discovery [20, 22, 37, 21], Bayesian analyses [19, 34], biomarker identification [35], multi-omics analyses [8, 9], and analyses of profiles from longitudinal studies [28, 33]. Low-cost sequencing has meant that an increasing number of metagenomic data sets are being generated [29].…”
Section: Introductionmentioning
confidence: 99%
“…The importance of the human microbiome has been increasingly recognized in biomedicine, due to its association with many complex diseases, such as obesity (Turnbaugh et al, 2009), cardiovascular disease (Koeth et al, 2013), diabetes (Qin et al, 2012;Dobra et al, 2019;Ren et al, 2020), liver cirrhosis (Qin et al, 2014), inflammatory bowel disease (Halfvarson et al, 2017), psoriasis (Tett et al, 2017), and colorectal cancer (Zackular et al, 2016), and its response to cancer immunotherapy (Frankel et al, 2017;Gopalakrishnan et al, 2018;Zitvogel et al, 2018). Advances in high-throughput next generation sequencing technologies (e.g., 16S ribosomal RNA [rRNA] sequencing, shotgun sequencing) make it possible to fully characterize the human microbiome, better understand the risk factors (e.g., clinical, genetic, environmental) that shape the human microbiome, and decipher the function and impact of the microbiome profile on human health and diseases (Li, 2015;Chen and Li, 2016;Zhu et al, 2017;Zhang et al, 2018;Reyes-Gibby et al, 2020;Sun et al, 2020;Wang et al, 2020b).…”
Section: Introductionmentioning
confidence: 99%